Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver

DENVER, July 7 /PRNewswire/ -- Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer. Screening Breast Ultrasound (SBU) is a highly effective technology developed to complement mammography in women with radiologically dense breasts and other risk factors.

"Screening breast ultrasound is part of our ongoing mission to provide comprehensive breast care to the community and to save lives through early detection," said Lora D. Barke, D.O., medical director of the Invision Sally Jobe Breast Network.

The new, FDA-cleared technology is ideal for women who have dense breast tissue. It can also be used in patients who are at an elevated risk for breast cancer due to a personal or family history of the disease.

As an adjunct to mammography, SBU has proven particularly effective at finding small, deadly cancers in dense-breasted women. In a recently published study of more than 4,400 women, SBU plus mammography doubled the number of cancers found compared to mammography alone.(1)

Unlike traditional ultrasound, SBU is a computer-aided system equipped with a mechanical arm to aid the technologist in acquiring images of the breast. Advanced software is then used to create a video loop of the images for interpretation, giving the radiologist a unique view of the breast.

Even though SBU is FDA cleared, it typically takes three to five years after such FDA clearance for procedure codes and insurance guidelines to be established. The proven benefit of preclinical breast cancer detection combined with the weight of medical evidence supporting SBU is powerful enough that Invision Sally Jobe is now offering this supplemental screening procedure to women as an out-of-pocket expense.

A large-scale clinical trial in 2008 demonstrated that the sensitivity of mammography is reduced in women whose tissue density is greater than 50 to 60 percent.(2) Furthermore, research presented at this year's American Association for Cancer Research (AACR) Annual Meeting showed that women with breast density of at least 75 percent on a mammogram have four- to five-times greater risk of breast cancer than women with little or no density.(3)

The SBU procedure takes approximately 45 minutes and requires no breast compression or injections. The exam uses no ionizing radiation, so it is safe to receive frequently, and is also safe for pregnant women. Unlike other breast ultrasound exams, SBU is intended to scan the entire breast, not just specific regions, which is why it is useful as a screening — versus diagnostic — tool.

Screening Breast Ultrasound is one of several options available at Invision Sally Jobe for breast cancer screening and risk reduction. For more information on Screening Breast Ultrasound, women should ask their doctor, contact Invision Sally Jobe at 720-493-3277 or visit www.InvisionSallyJobe.com. On Facebook: www.Facebook.com/InvisionSallyJobe.

About Invision Sally Jobe

Invision Sally Jobe is a network of medical imaging centers that offers full-service diagnostic imaging in several convenient Denver metro locations. Services include state-of-the-art MRI, CT, digital mammography, diagnostic x-ray, ultrasound, pain management, NIVA and osteoporosis testing. The Invision Sally Jobe Breast Network is Colorado's only Certified Quality Breast Center. Invision Sally Jobe is a joint venture with HealthOne and Radiology Imaging Associates and is committed to excellence in service to patients and referring physicians. Call 720-493-3700 or visit www.InvisionSallyJobe.com for more information.

Sources:

(1) European Radiology: http://www.springerlink.com/content/2308632250528700/fulltext.pdf

(2) Radiology: http://radiology.rsna.org/content/246/2/376.full.pdf+html

(3) Association for Cancer Research: http://www.aacr.org/home/public--media/aacr-press-releases.aspx?d=1830

SOURCE Invision Sally Jobe